drugset / Trial / NCT02069821

Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects

NCT02069821

Phase 1 Completed 56 enrolled HK inno.N Corporation
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of the study is to assess the pharmacokinetic interactions between amlodipine besylate/valsartan and atorvastatin single or co-administered in healthy volunteers.

Timeline

Start
2014-03
Primary completion
2014-03
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg Oral
Subject Atorvastatin Small molecule 40 mg Oral
Subject Valsartan Small molecule 160 mg Oral

Indications

No indication recorded.